Combination of the oral histone deacetylase inhibitor resminostat with oncolytic measles vaccine virus as a new option for epi-virotherapeutic treatment of hepatocellular carcinoma

Ruf, Benjamin; Berchtold, Susanne; Venturelli, Sascha; Burkard, Markus; Smirnow, Irina; Prenzel, Tanja; Henning, Stefan W.; Lauer, Ulrich M.

dc.contributor.author	Ruf, Benjamin
dc.contributor.author	Berchtold, Susanne
dc.contributor.author	Venturelli, Sascha
dc.contributor.author	Burkard, Markus
dc.contributor.author	Smirnow, Irina
dc.contributor.author	Lauer, Ulrich Manfred
dc.date.accessioned	2017-11-10T15:26:35Z
dc.date.available	2017-11-10T15:26:35Z
dc.date.issued	2015
dc.identifier.issn	2372-7705
dc.identifier.uri	http://hdl.handle.net/10900/78382
dc.language.iso	en	de_DE
dc.publisher	Nature Publishing Group	de_DE
dc.relation.uri	http://dx.doi.org/10.1038/mto.2015.19	de_DE
dc.rights	info:eu-repo/semantics/closedAccess
dc.subject.ddc	610	de_DE
dc.title	Combination of the oral histone deacetylase inhibitor resminostat with oncolytic measles vaccine virus as a new option for epi-virotherapeutic treatment of hepatocellular carcinoma	de_DE
dc.type	Article	de_DE
utue.quellen.id	20170803141528_00796
utue.personen.roh	Ruf, Benjamin
utue.personen.roh	Berchtold, Susanne
utue.personen.roh	Venturelli, Sascha
utue.personen.roh	Burkard, Markus
utue.personen.roh	Smirnow, Irina
utue.personen.roh	Prenzel, Tanja
utue.personen.roh	Henning, Stefan W.
utue.personen.roh	Lauer, Ulrich M.
dcterms.isPartOf.ZSTitelID	Molecular Therapy - Oncolytics	de_DE
dcterms.isPartOf.ZS-Issue	Article UNSP 150019	de_DE
dcterms.isPartOf.ZS-Volume	2	de_DE
utue.fakultaet	04 Medizinische Fakultät	de_DE